中财网 中财网股票行情
恒瑞医药(600276)财务分析指标    年份：
截止日期2026-06-302026-03-312025-12-312025-09-302025-06-30
营业总收入(万元)1545558.37814056.533162941.622318808.191576119.36
营业收入(万元)1545558.37814056.533162941.622318808.191576119.36
营业总成本(万元)1131314.04566732.242320389.331694966.541089980.16
营业成本(万元)211334.30109094.91436265.58319544.12211496.22
净利润(万元)443546.36227000.23772204.70577085.74447655.04
归属于母公司的净利润(万元)446543.94228226.82771105.48575116.95445010.64
营业利润(万元)508774.25260744.35899000.28662451.24515889.27
利润总额(万元)495241.75255686.21870762.55641200.78505093.42
少数股东损益(万元)-15.70-127.35594.74906.56456.43
基本每股收益(元)0.68(元)0.34(元)1.19(元)0.89(元)0.70(元)
稀释每股收益(元)0.68(元)0.34(元)1.18(元)0.89(元)0.70(元)
非经常性损益(万元)--10986.9429764.9216181.98--
扣除非经常性损益后净利润(万元)372958.90217239.88741340.56558934.97427284.85
总资产(万元)7077312.207129386.246986731.586832754.056289351.71
总负债(万元)578338.16714677.62807049.24829502.25386371.91
归属于母公司股东权益合计(万元)6446643.026362626.446127206.865950425.085846483.12
股东权益合计(万元)6498974.046414708.636179682.346003251.805902979.80
实收资本(股本)(万元)663719.99663719.99663719.99663719.99663719.99
资本公积(万元)1295582.671288296.761293461.631293203.731287149.67
未分配利润(万元)4331273.364245562.314017335.483834256.843704150.52
经营活动产生的现金流量净额(万元)198700.3978644.591123537.81911043.03430045.33
经营活动现金流入小计(万元)1435715.82692435.133483415.992697282.281612379.40
经营活动现金流出小计(万元)1237015.44613790.542359878.181786239.251182334.08
投资活动产生的现金流量净额(万元)-182459.84-72374.60-274050.24-152626.69-108473.29
投资活动现金流入小计(万元)6820.691137.2922140.3918819.5618283.20
投资活动现金流出小计(万元)189280.5373511.90296190.63171446.25126756.49
筹资活动产生的现金流量净额(万元)-158978.66-18571.70778170.74809102.04803949.50
筹资活动现金流入小计(万元)149109.5529953.421226567.911078027.321035193.79
筹资活动现金流出小计(万元)308088.2048525.12448397.17268925.28231244.29
期末现金及现金等价物余额(万元)3803152.493968283.414015555.273976770.813554260.51
最后修改日期2026-08-192026-04-232026-03-272025-10-282025-08-21
↑返回页顶↑

转至恒瑞医药（600276）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。